Product Information
AMLODIPINE-ATORVAST 2.5-40 MG is a generic product labeled by Prasco Laboratories, priced at $5.0125 per EA under NDC 66993026530. Its NADAC has been published 67 times since Mar 19, 2025.
Strength
2.5; 40 mg/1; mg/1
Manufacturer
Prasco LaboratoriesNDC
66993026530
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021540On Market Since
3/14/2022
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-ATORVAST 2.5-40 MG has been published 67 times since Mar 19, 2025, and over the history we have for it it has risen 10.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.0125 per EA |
|---|---|
| All-time high | $5.0125 (Jun 24, 2026) |
| All-time low | $4.2796 (Jul 23, 2025) |
| 52-week high | $5.0125 |
| 52-week low | $4.2796 |
| Median price | $4.4866 |
| Average price | $4.5169 |
| Largest weekly change | +8.5% (Apr 22, 2026) |
| Weeks tracked | 67 |
| Tracking since | Mar 19, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of AMLODIPINE-ATORVAST 2.5-40 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-ATORVAST 2.5-40 MG, manufactured by Prasco Laboratories, is $5.0125 per EA (NDC 66993026530), effective Jun 24, 2026.
How has the price of AMLODIPINE-ATORVAST 2.5-40 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-ATORVAST 2.5-40 MG has risen 10.7%. It has been tracked across 67 weekly CMS publications since Mar 19, 2025.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-ATORVAST 2.5-40 MG?
Since Mar 19, 2025, the NADAC for AMLODIPINE-ATORVAST 2.5-40 MG has ranged from a low of $4.2796 (Jul 23, 2025) to a high of $5.0125 (Jun 24, 2026), with a median of $4.4866 per EA.
Are there cheaper alternatives to AMLODIPINE-ATORVAST 2.5-40 MG?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as AMLODIPINE-ATORVAST 2.5-40 MG, but none are currently priced below it.
Who manufactures AMLODIPINE-ATORVAST 2.5-40 MG?
AMLODIPINE-ATORVAST 2.5-40 MG (NDC 66993026530) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification